DT Investment Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.24K | Hold |
168
| – | – | ﹤0.01% | 413 |
|
|
2025
Q1 | $11.9K | Hold |
168
| – | – | ﹤0.01% | 378 |
|
|
2024
Q4 | $11K | Sell |
168
-55
| -25% | -$3.62K | ﹤0.01% | 399 |
|
|
2024
Q3 | $15.7K | Buy |
223
+55
| +33% | +$3.87K | ﹤0.01% | 389 |
|
|
2024
Q2 | $13.8K | Sell |
168
-63
| -27% | -$5.19K | ﹤0.01% | 349 |
|
|
2024
Q1 | $20.2K | Hold |
231
| – | – | ﹤0.01% | 286 |
|
|
2023
Q4 | $20.7K | Hold |
231
| – | – | ﹤0.01% | 275 |
|
|
2023
Q3 | $20.4K | Hold |
231
| – | – | ﹤0.01% | 259 |
|
|
2023
Q2 | $20.6K | Hold |
231
| – | – | ﹤0.01% | 265 |
|
|
2023
Q1 | $22.4K | Hold |
231
| – | – | ﹤0.01% | 258 |
|
|
2022
Q4 | $23.9K | Hold |
231
| – | – | ﹤0.01% | 251 |
|
|
2022
Q3 | $20K | Buy |
+231
| New | +$20K | ﹤0.01% | 250 |
|